Company news
Callitas Health Inc news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
CSE Bulletin: Delist - Callitas Health Inc. (LILY)
December 8, 2021
Callitas Provides Third Default Status Report
June 12, 2019
Callitas Provides Second Default Status Report
May 30, 2019
Callitas Health, Inc. Announces Closing of Private Placements
May 23, 2019
Callitas Provides Status Update
May 15, 2019
Callitas Health Announces Late Filing of Annual Financial Disclosure
May 1, 2019
Callitas Health Announces Notice of Allowance for a Biphasic Oral Cannabinoid Patent by U.S. Patent Office, Next Evolution of Cannabis Delivery
April 25, 2019
Callitas Health Signs Letter of Intent with Simply Wholeistic, LLC to Supply Cannastrip Technology and Dietary Supplements Nationwide
April 22, 2019
Callitas Health Announces the Promotion of Joshua Maurice to Vice President of Sales and Business Development
March 12, 2019
Callitas Health Expands Agreement with NFI Consumer Healthcare to Distribute Co-Branded Product
February 26, 2019
Callitas Health, Inc., Signs a Definitive Patent Technology Assignment Agreement to Acquire Additional Novel Cannabis Dosing Technologies
October 2, 2018
Callitas Health, Inc. Announces Corporate Update
September 18, 2018
InvestmentPitch Media Video Discusses Callitas Health's Consulting Agreement with BFS Innovations and Pure Leaf Group for Cannabis Delivery Technology - Video Available on Investmentpitch.com
August 24, 2018
Callitas Health, Inc. Signs Partnership Agreement with BFS Innovations and Pure Leaf Group
August 17, 2018
Callitas Health Accelerates Commercial Licensing and Engages Feyeur & Trogue, a Specialty Healthcare Consulting Firm
January 22, 2018
Callitas Health Engages Dr. Laura Berman, World-Renowned Sex Educator, Researcher and Therapist as Chief Health Advisor
January 4, 2018
Callitas Announces New Interim CEO and Refiling of Quarter 2 Interim Financial Statements
January 3, 2018
Callitas Health Announces Patent Application for CannaMint Strips
November 16, 2017
Callitas Health Announces Addition of Joshua Maurice to Strategic Management Team
October 25, 2017
Callitas Announces Positive FDA Response to Extrinsa Pre-IND Submission
October 11, 2017
ToConceive launches new paraben-free formula to promote natural conception
September 29, 2017
ToConceive Launches New Paraben-Free Formula to Promote Natural Conception
September 29, 2017
Callitas Health Inc. Provides Report to Shareholders Highlighting Product Development and Strategic Advancements
September 22, 2017
M Pharmaceutical Announces Name Change to Callitas Health Inc. and Share Consolidation
September 15, 2017
M Pharmaceutical USA Announces a Change of Name to Callitas Therapeutics
August 1, 2017
M Pharmaceutical USA Announces a Change of Name to Callitas Therapeutics
August 1, 2017